LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 19.76

Change

0.00 (0.00)%

Market Cap

CAD 0.22B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.39 (+0.95%)

CAD 3.37B
ZWU:CA BMO Covered Call Utilities ETF

-0.02 (-0.18%)

CAD 1.79B
XIT:CA iShares S&P/TSX Capped Informa..

+1.25 (+1.98%)

CAD 0.82B
HTA:CA Harvest Tech Achievers Growth ..

+0.11 (+0.67%)

CAD 0.63B
TXF:CA First Asset Tech Giants Covere..

+0.16 (+0.88%)

CAD 0.61B
XHC:CA iShares Global Healthcare (CAD..

+0.15 (+0.22%)

CAD 0.57B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.09 (+0.39%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.08 (+0.27%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

+0.47 (+0.80%)

CAD 0.30B
HUTL:CA Harvest Equal Weight Global Ut..

-0.07 (-0.38%)

CAD 0.27B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.60% 63% D 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.60% 60% D- 67% D+
Trailing 12 Months  
Capital Gain -8.14% 23% F 17% F
Dividend Return 2.23% 55% F 38% F
Total Return -5.90% 20% F 16% F
Trailing 5 Years  
Capital Gain 7.04% 11% F 27% F
Dividend Return 39.71% 76% C+ 79% B-
Total Return 46.75% 23% F 34% F
Average Annual (5 Year Horizon)  
Capital Gain 0.34% 23% F 31% F
Dividend Return 1.53% 11% F 27% F
Total Return 1.19% 53% F 43% F
Risk Return Profile  
Volatility (Standard Deviation) 6.73% 97% N/A 86% B+
Risk Adjusted Return 22.67% 20% F 36% F
Market Capitalization 0.22B 65% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.